Biological and information technology integration solution provider Jinguan Technology completed 200 million yuan in angel round financing

shows 1171℃

Biological and information technology integration solution provider Jinguan Technology completed 200 million yuan in angel round financing - Lujuba本轮资金将用于两款BTIT核心产品的研发及产品化


作者:Darin

编辑:tuya

出品:财经涂鸦


上海近观科技有限责任公司(以下简称“近观科技” ) recently announced that led investment from Shanghai Lianhe Investment, followed by Honghui Fund, Lianxin Capital , Chende Capital and Shanghai Industrial Technology Research Institute followed by 200 million yuan in angel round financing .

Biological and information technology integration solution provider Jinguan Technology completed 200 million yuan in angel round financing - Lujuba

Source: Tianyanzha

Close view technology said that this round of biological technology will be used to build two BTIT (BioTech & InfoTech) core product development and commercialization zz7 An integrated platform for product development and application, providing a complete customized BTIT overall solution.

Jinguan Technology was established in 2020 by Chen Chang, a national expert in the cross-integration field of biology and information technology (BTIT), and was incubated by the Shanghai Micro Technology Industrial Research Institute. It focuses on the combination of integrated circuit chip technology and biotechnology, A cross-border high-tech enterprise serving the life sciences and healthcare industries. The core members of the team are professionals from top R&D institutions at home and abroad such as imec, GE, GF, IBM, Harvard University , Stanford University , Imperial College London, Tsinghua University , Peking University , Chinese Academy of Sciences . The professional background of the team covers interdisciplinary fields such as integrated circuit technology, silicon-based optoelectronics, biotechnology, AI algorithm, bioinformatics, optical engineering and clinical practice.

The early research and development goal of Jinguan Technology is based on the cross-integration of biology and information technology (BTIT). Difficult technologies and products in the industry such as blood analysis technology (such as blood sugar) and single-molecule technology (such as sequencing).

As early as the 1980s in the 20th century, bioinformatics has become an important tool for life science research. Some countries have established the database of the National Center for Biotechnology Information (NCBI) in the United States, the database of the European Bioinformatics Institute (EBI) and Japan DNA Database (DDBJ) three major databases. In addition, the development of the " Human Genome Project" has triggered a sharp increase in life science omics data such as genome, transcription group, epigenetic group, proteome , metabolome , and promoted information Large-scale application of technology in life science fields.

More typically, a number of large pharmaceutical companies or pharmaceutical investors have launched strategic cooperation with information technology giants, including Google, Microsoft, Intel, etc., to accelerate industrial integration.


Biological and information technology integration solution provider Jinguan Technology completed 200 million yuan in angel round financing - Lujuba

Source: Proceedings of the Chinese Academy of Sciences

Information technology has the functions of collection, processing, storage, integration, mining, and analysis. Predictable direction of development, driving the research of biological science into a newer category. At the same time, the information exchange and processing of neurons in organisms,Gene expression and regulation can also provide more ideas for the development of information technology. The great development of biotechnology has given birth to the demand for big data storage and analysis; the great development of information technology has accelerated the development of biologically inspired solutions. The integrated development of biotechnology and information technology has also become an important driving force for a new round of scientific and technological revolution.


Tags: shows